<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38155884</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study.</ArticleTitle><Pagination><StartPage>1303183</StartPage><MedlinePgn>1303183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1303183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1303183</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long COVID is a clinical entity characterized by persistent health problems or development of new diseases, without an alternative diagnosis, following SARS-CoV-2 infection that affects a significant proportion of individuals globally. It can manifest with a wide range of symptoms due to dysfunction of multiple organ systems including but not limited to cardiovascular, hematologic, neurological, gastrointestinal, and renal organs, revealed by observational studies. However, a causal association between the genetic predisposition to COVID-19 and many post-infective abnormalities in long COVID remain unclear.</AbstractText><AbstractText Label="METHODS">Here we employed Mendelian randomization (MR), a robust genetic epidemiological approach, to investigate the potential causal associations between genetic predisposition to COVID-19 and long COVID symptoms, namely pulmonary (pneumonia and airway infections including bronchitis, emphysema, asthma, and rhinitis), neurological (headache, depression, and Parkinson's disease), cardiac (heart failure and chest pain) diseases, and chronic fatigue. Using two-sample MR, we leveraged genetic data from a large COVID-19 genome-wide association study and various disorder-specific datasets.</AbstractText><AbstractText Label="RESULTS">This analysis revealed that a genetic predisposition to COVID-19 was significantly causally linked to an increased risk of developing pneumonia, airway infections, headache, and heart failure. It also showed a strong positive correlation with chronic fatigue, a frequently observed symptom in long COVID patients. However, our findings on Parkinson's disease, depression, and chest pain were inconclusive.</AbstractText><AbstractText Label="CONCLUSION">Overall, these findings provide valuable insights into the genetic underpinnings of long COVID and its diverse range of symptoms. Understanding these causal associations may aid in better management and treatment of long COVID patients, thereby alleviating the substantial burden it poses on global health and socioeconomic systems.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Shenoy, Udupa, KS, Babu, K, Jain, Das and Upadhyai.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shenoy</LastName><ForeName>Pooja U</ForeName><Initials>PU</Initials><AffiliationInfo><Affiliation>Division of Data Analytics, Bioinformatics and Structural Biology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udupa</LastName><ForeName>Hrushikesh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Yenepoya Medical College and Hospital, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ks</LastName><ForeName>Jyothika</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Sangeetha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Statistics, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K</LastName><ForeName>Nikshita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Statistics, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Neha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Statistics, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Das</LastName><ForeName>Ranajit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Data Analytics, Bioinformatics and Structural Biology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Upadhyai</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Public Health. 2024 Feb 12;12:1380811. doi: 10.3389/fpubh.2024.1380811</RefSource><PMID Version="1">38410661</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-induced cardiac disease</Keyword><Keyword MajorTopicYN="N">COVID-induced fatigue</Keyword><Keyword MajorTopicYN="N">COVID-induced neurological disorders</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38155884</ArticleId><ArticleId IdType="pmc">PMC10752946</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1303183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>(WHO) WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus. (2021) Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-21.1 (Accessed October 6, 2021).</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. . Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. (2022) 12:9950. doi: 10.1038/s41598-022-13495-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention CfDCa . Post-COVID conditions. (2023) Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a Meta-analysis and systematic review. J Infect Dis. (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. (2022) 5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Caze AB, Cerqueira-Silva T, Bomfim AP, de Souza GL, Azevedo AC, Brasil MQ, et al. . Prevalence and risk factors for long COVID after mild disease: a cohort study with a symptomatic control group. J Glob Health. (2023) 13:06015. doi: 10.7189/jogh.13.06015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06015</ArticleId><ArticleId IdType="pmc">PMC10173895</ArticleId><ArticleId IdType="pubmed">37166260</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;e16. doi: 10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. . Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. (2021) 10:1408. doi: 10.3390/pathogens10111408, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Martin-Guerrero JD, Florencio LL, Navarro-Pardo E, Rodriguez-Jimenez J, Torres-Macho J, et al. . Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. (2023) 51:61&#x2013;9. doi: 10.1007/s15010-022-01822-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira-Silva T, Shah SA, Robertson C, Sanchez M, Katikireddi SV, de Araujo OV, et al. . Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: a test-negative design case-control study. PLoS Med. (2023) 20:e1004156. doi: 10.1371/journal.pmed.1004156, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004156</ArticleId><ArticleId IdType="pmc">PMC9879484</ArticleId><ArticleId IdType="pubmed">36630477</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V, Nakanishi T, Jones SE, Andrews SJ, Karjalainen J, Cort&#xe9;s B, et al. . Genome-wide association study of long COVID. medRxiv 2023.06.29.23292056. (2023). doi: 10.1101/2023.06.29.23292056</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.29.23292056</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi: 10.1038/s41591-022-01840-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. (2022) 103:154&#x2013;62. doi: 10.1016/j.bbi.2022.04.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators. Wulf Hanson S, Abbafati C, Aerts JG, al-Aly Z, Ashbaugh C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. (2022) 328:1604&#x2013;15. doi: 10.1001/jama.2022.18931, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. . Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. (2021) 76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. . Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. (2021) 299:E177&#x2013;86. doi: 10.1148/radiol.2021203153</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri L, Moss S, Khan FA, Chi W, Xia J, Robinson K, et al. . Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. (2023) 78:191&#x2013;201. doi: 10.1136/thoraxjnl-2021-218275, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218275</ArticleId><ArticleId IdType="pubmed">35338102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. (2021) 4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W, et al. . Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimers Dement. (2022) 18:1047&#x2013;66. doi: 10.1002/alz.12644, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth DA, Chamley R, Barker-Davies R, O'Sullivan O, Ladlow P, Mitchell JL, et al. . Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLoS One. (2022) 17:e0267392. doi: 10.1371/journal.pone.0267392, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267392</ArticleId><ArticleId IdType="pmc">PMC9187094</ArticleId><ArticleId IdType="pubmed">35687603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, Harriott AM, Garcia-Azorin D, Labastida-Ramirez A, et al. . Long COVID headache. J Headache Pain. (2022) 23:93. doi: 10.1186/s10194-022-01450-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. . Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. (2022) 9:815&#x2013;27. doi: 10.1016/S2215-0366(22)00260-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, et al. . A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol. (2020) 19:804&#x2013;5. doi: 10.1016/S1474-4422(20)30305-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30305-7</ArticleId><ArticleId IdType="pmc">PMC7494295</ArticleId><ArticleId IdType="pubmed">32949534</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao AR, Hidayathullah SM, Hegde K, Adhikari P. Parkinsonism: an emerging post COVID sequelae. IDCases. (2022) 27:e01388. doi: 10.1016/j.idcr.2022.e01388, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2022.e01388</ArticleId><ArticleId IdType="pmc">PMC8733235</ArticleId><ArticleId IdType="pubmed">35018281</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez A, Wamil M, Telford A, Carapella V, Borlotti A, Monteiro D, et al. . Cardiac impairment in long Covid 1-year post SARS-CoV-2 infection. Eur Heart J. (2022) 43:43(Supplement_2). doi: 10.1093/eurheartj/ehac544.219</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.219</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi: 10.1038/s41591-022-01689-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi: 10.1016/S2213-8587(22)00044-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Eichert N, et al. . Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. J R Soc Med. (2023) 116:97&#x2013;112. doi: 10.1177/01410768231154703</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L, Gazit S, Pinto Y, Perez G, Mizrahi Reuveni M, Yehoshua I, et al. . Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide cohort study. Scand J Prim Health Care. (2022) 40:342&#x2013;9. doi: 10.1080/02813432.2022.2139480, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02813432.2022.2139480</ArticleId><ArticleId IdType="pmc">PMC9848375</ArticleId><ArticleId IdType="pubmed">36314555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bygdell M, Leach S, Lundberg L, Gyll D, Martikainen J, Santosa A, et al. . A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the international classification of diseases tenth revision diagnosis code (U09.9): a population-based cohort study. Int J Infect Dis. (2023) 126:104&#x2013;13. doi: 10.1016/j.ijid.2022.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.11.021</ArticleId><ArticleId IdType="pmc">PMC9678230</ArticleId><ArticleId IdType="pubmed">36410693</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. (2003) 32:1&#x2013;22. doi: 10.1093/ije/dyg070, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg070</ArticleId><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranova A, Cao H, Zhang F. Causal effect of COVID-19 on Alzheimer's disease: a Mendelian randomization study. J Med Virol. (2023) 95:e28107. doi: 10.1002/jmv.28107</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28107</ArticleId><ArticleId IdType="pmc">PMC9539282</ArticleId><ArticleId IdType="pubmed">36039844</ArticleId></ArticleIdList></Reference><Reference><Citation>Li GH, Tang CM, Cheung CL. COVID-19 and thyroid function: a bi-directional two-sample Mendelian randomization study. Thyroid. (2022) 32:1037&#x2013;50. doi: 10.1089/thy.2022.0243, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2022.0243</ArticleId><ArticleId IdType="pubmed">35734897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Tan JS, Liu L, Wang Y, Hua L, Qian Q. Genetic predisposition between COVID-19 and four mental illnesses: a bidirectional, two-sample Mendelian randomization study. Front Psych. (2021) 12:746276. doi: 10.3389/fpsyt.2021.746276</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.746276</ArticleId><ArticleId IdType="pmc">PMC8564104</ArticleId><ArticleId IdType="pubmed">34744839</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Bai H, Qiao H, Du C, Yao P, Zhang Y, et al. . Causal effects of COVID-19 on cancer risk: a Mendelian randomization study. J Med Virol. (2023) 95:e28722. doi: 10.1002/jmv.28722, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28722</ArticleId><ArticleId IdType="pubmed">37185860</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey SG. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. (2018) 362:k601. doi: 10.1136/bmj.k601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k601</ArticleId><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>GenomeAsia KC. The GenomeAsia 100K project enables genetic discoveries across Asia. Nature. (2019) 576:106&#x2013;11. doi: 10.1038/s41586-019-1793-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1793-z</ArticleId><ArticleId IdType="pmc">PMC7054211</ArticleId><ArticleId IdType="pubmed">31802016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. (2015) 4:7. doi: 10.1186/s13742-015-0047-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13742-015-0047-8</ArticleId><ArticleId IdType="pmc">PMC4342193</ArticleId><ArticleId IdType="pubmed">25722852</ArticleId></ArticleIdList></Reference><Reference><Citation>Teumer A. Common methods for performing Mendelian randomization. Front. Cardiovasc. Med. (2018) 5:51. doi: 10.3389/fcvm.2018.00051, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00051</ArticleId><ArticleId IdType="pmc">PMC5985452</ArticleId><ArticleId IdType="pubmed">29892602</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashboard WCC . (2023) Available at: https://covid19.who.int.</Citation></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. doi: 10.1016/j.jchf.2021.10.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. . Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. (2021) 73:e1089&#x2013;98. doi: 10.1093/cid/ciaa1750, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentilotti E, Gorska A, Tami A, Gusinow R, Mirandola M, Rodriguez Bano J, et al. . Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. (2023) 62:102107. doi: 10.1016/j.eclinm.2023.102107, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102107</ArticleId><ArticleId IdType="pmc">PMC10466236</ArticleId><ArticleId IdType="pubmed">37654668</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent R, Correia P, Lachand R, Diconne E, Ezingeard E, Bruna F, et al. . Long-term outcomes of COVID-19 intensive care unit survivors and their family members: a one year follow-up prospective study. Front Public Health. (2023) 11:1236990. doi: 10.3389/fpubh.2023.1236990</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1236990</ArticleId><ArticleId IdType="pmc">PMC10442651</ArticleId><ArticleId IdType="pubmed">37614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess H, Nyland M, Hausken T, Follestad I, Nyland HI. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence. BMC Gastroenterol. (2012) 12:13. doi: 10.1186/1471-230X-12-13, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-230X-12-13</ArticleId><ArticleId IdType="pmc">PMC3292445</ArticleId><ArticleId IdType="pubmed">22316329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575. doi: 10.1136/bmj.38933.585764.AE, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:5104. doi: 10.1038/s41467-022-32507-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker AME, Maffitt NJ, Del Vecchio A, McKeating KM, Baker MR, Baker SN, et al. . Neural dysregulation in post-COVID fatigue. Brain Commun. (2023) 5:fcad122. doi: 10.1093/braincomms/fcad122</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad122</ArticleId><ArticleId IdType="pmc">PMC10257363</ArticleId><ArticleId IdType="pubmed">37304792</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J, Schwichtenberg K, Hartung TJ, Rekers S, Chien C, Boesl F, et al. . Structural brain changes in patients with post-COVID fatigue: a prospective observational study. EClinicalMedicine. (2023) 58:101874. doi: 10.1016/j.eclinm.2023.101874, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Laksono BM, de Vrij FMS, Kushner SA, Harschnitz O, van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. (2022) 45:358&#x2013;68. doi: 10.1016/j.tins.2022.02.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. (2022) 604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. (2020) 382:2268&#x2013;70. doi: 10.1056/NEJMc2008597, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi AM, Ahmed O, Giliberto L, Castillo M. Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol. (2020) 41:1173&#x2013;6. doi: 10.3174/ajnr.A6595, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6595</ArticleId><ArticleId IdType="pmc">PMC7357664</ArticleId><ArticleId IdType="pubmed">32439646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, et al. . SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. (2020) 162:1491&#x2013;4. doi: 10.1007/s00701-020-04374-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04374-x</ArticleId><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. (2022) 375:267&#x2013;9. doi: 10.1126/science.abm2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. . (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. (2021) 48:2823&#x2013;33. doi: 10.1007/s00259-021-05215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Queneau M, Sanchez Ortiz M, Msika EF, Farid K, Paquet C. Cognitive decline and brainstem hypometabolism in long COVID: a case series. Brain Behav. (2022) 12:e2513. doi: 10.1002/brb3.2513</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, Oddi A, Peluso MJ, Asken BM, Henrich TJ, Kelly JD, et al. . Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. (2022) 9:221&#x2013;6. doi: 10.1002/acn3.51498, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, Ning B, Huang Z, Monjure CJ, et al. . Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. (2022) 13:1745. doi: 10.1038/s41467-022-29440-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29440-z</ArticleId><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, et al. . Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia. (2022) 42:804&#x2013;9. doi: 10.1177/03331024211068074, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211068074</ArticleId><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Navarro-Santana M, Gomez-Mayordomo V, Cuadrado ML, Garcia-Azorin D, Arendt-Nielsen L, et al. . Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol. (2021) 28:3820&#x2013;5. doi: 10.1111/ene.15040</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues AN, Dias ARN, Paranhos ACM, Silva CC, Bastos TDR, de Brito BB, et al. . Headache in long COVID as disabling condition: a clinical approach. Front Neurol. (2023) 14:1149294. doi: 10.3389/fneur.2023.1149294, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1149294</ArticleId><ArticleId IdType="pmc">PMC10076861</ArticleId><ArticleId IdType="pubmed">37034080</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo S-S, Chen W, Jung KL, Azamor T, Choi UY, Zhang P, et al. . Immunometabolic rewiring in long COVID patients with chronic headache. bioRxiv 2023.03.06.531302. (2023). doi: 10.1101/2023.03.06.531302</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.06.531302</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa BAD, Silva L, Mendes M, Karmann &#xcd;, Campos B, Nogueira M, et al. . Anxiety and depression are associated with limbic atrophy and severe disruption of brain functional connectivity after mild COVID-19 infection (S21.007). Neurology. (2023) 100:1998. doi: 10.1212/WNL.0000000000202252</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000202252</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. (2022) 37:539&#x2013;48. doi: 10.1007/s10654-022-00847-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. doi: 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Re&#x2019;em Y, Stelson EA, Davis HE, McCorkell L, Wei H, Assaf G, et al. . Factors associated with psychiatric outcomes and coping in long COVID. Nat. Mental Health. (2023) 1:361&#x2013;72. doi: 10.1038/s44220-023-00064-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44220-023-00064-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer ME, Teixeira AL. Neuroinflammation in mood disorders: role of regulatory immune cells. Neuroimmunomodulation. (2021) 28:99&#x2013;107. doi: 10.1159/000515594, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515594</ArticleId><ArticleId IdType="pubmed">33951643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, Gilbert RM. Epidemiology of Parkinson disease. Neurol Clin. (2016) 34:955&#x2013;65. doi: 10.1016/j.ncl.2016.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2016.06.012</ArticleId><ArticleId IdType="pubmed">27720003</ArticleId></ArticleIdList></Reference><Reference><Citation>Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious etiologies of parkinsonism: Pathomechanisms and clinical implications. Front Neurol. (2019) 10:652. doi: 10.3389/fneur.2019.00652, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00652</ArticleId><ArticleId IdType="pmc">PMC6593078</ArticleId><ArticleId IdType="pubmed">31275235</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, et al. . COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. (2021) 595:107&#x2013;13. doi: 10.1038/s41586-021-03570-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. (2020) 130:3950&#x2013;3. doi: 10.1172/JCI140183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140183</ArticleId><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395:1417&#x2013;8. doi: 10.1016/S0140-6736(20)30937-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, 3rd, et al. . COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. (2021) 128:1214&#x2013;36. doi: 10.1161/CIRCRESAHA.121.317997, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. (2020) 142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. (2020) 17:543&#x2013;58. doi: 10.1038/s41569-020-0413-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. (2021) 27:258&#x2013;63. doi: 10.1016/j.cmi.2020.09.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. . Association of Cardiac Injury with Mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. (2020) 5:802&#x2013;10. doi: 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811&#x2013;8. doi: 10.1001/jamacardio.2020.1017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj R, Sinclair HC, Patel K, Low B, Pericao A, Manisty C, et al. . Delayed-onset myocarditis following COVID-19. Lancet Respir Med. (2021) 9:e32&#x2013;4. doi: 10.1016/S2213-2600(21)00085-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00085-0</ArticleId><ArticleId IdType="pmc">PMC7906752</ArticleId><ArticleId IdType="pubmed">33617781</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. (2021) 11:e048391. doi: 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohun J, Dorniak K, Faran A, Kocha&#x144;ska A, Zacharek D, Dani&#x142;owicz-Szymanowicz L. Long COVID-19 myocarditis and various heart failure presentations: a case series. J. Cardiovasc. Dev. Dis. (2022) 9:427. doi: 10.3390/jcdd9120427</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd9120427</ArticleId><ArticleId IdType="pmc">PMC9785067</ArticleId><ArticleId IdType="pubmed">36547424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liviero F, Scapellato ML, Folino F, Moretto A, Mason P, Pavanello S. Persistent increase of sympathetic activity in post-acute COVID-19 of Paucisymptomatic healthcare workers. Int J Environ Res Public Health. (2023) 20:1256512. doi: 10.3390/ijerph20010830</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010830</ArticleId><ArticleId IdType="pmc">PMC9820028</ArticleId><ArticleId IdType="pubmed">36613152</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, et al. . Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy. N Engl J Med. (2020) 383:496&#x2013;8. doi: 10.1056/NEJMc2010418, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010418</ArticleId><ArticleId IdType="pmc">PMC7204428</ArticleId><ArticleId IdType="pubmed">32348640</ArticleId></ArticleIdList></Reference><Reference><Citation>Laorden D, Dominguez-Ortega J, Carpio C, Barranco P, Villamanan E, Romero D, et al. . Long COVID outcomes in an asthmatic cohort and its implications for asthma control. Respir Med. (2023) 207:107092. doi: 10.1016/j.rmed.2022.107092, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.107092</ArticleId><ArticleId IdType="pmc">PMC9755318</ArticleId><ArticleId IdType="pubmed">36535372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Long-term lung abnormalities associated with COVID-19 pneumonia. Radiology. (2023) 306:e221806. doi: 10.1148/radiol.221806, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Kim BG, Chung SJ, Park DW, Park TS, Moon JY, et al. . New-onset asthma following COVID-19 in adults. J Allergy Clin Immunol Pract. (2023) 11:2228&#x2013;31. doi: 10.1016/j.jaip.2023.03.050, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2023.03.050</ArticleId><ArticleId IdType="pmc">PMC10116152</ArticleId><ArticleId IdType="pubmed">37084939</ArticleId></ArticleIdList></Reference><Reference><Citation>Celik E, Nelles C, Kottlors J, Fervers P, Goertz L, Pinto Dos Santos D, et al. . Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection. PLoS One. (2022) 17:e0263261. doi: 10.1371/journal.pone.0263261, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263261</ArticleId><ArticleId IdType="pmc">PMC8812925</ArticleId><ArticleId IdType="pubmed">35113939</ArticleId></ArticleIdList></Reference><Reference><Citation>Porru S, Monaco MGL, Spiteri G, Carta A, Pezzani MD, Lippi G, et al. . SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of health workers. Vaccines (Basel). (2022) 10:1193. doi: 10.3390/vaccines10020272</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020272</ArticleId><ArticleId IdType="pmc">PMC9415790</ArticleId><ArticleId IdType="pubmed">36016081</ArticleId></ArticleIdList></Reference><Reference><Citation>Violan C, Carrasco-Ribelles LA, Collatuzzo G, Ditano G, Abedini M, Janke C, et al. . Multimorbidity and serological response to SARS-CoV-2 nine months after 1st vaccine dose: European cohort of healthcare workers-Orchestra project. Vaccines (Basel). (2023) 11:1340. doi: 10.3390/vaccines11081340</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11081340</ArticleId><ArticleId IdType="pmc">PMC10459685</ArticleId><ArticleId IdType="pubmed">37631908</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>